loganin has been researched along with Diabetic Glomerulosclerosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, L; Kong, X; Meng, Y; Song, W; Wang, B; Wang, X; Yan, G; Yu, M; Yu, Y; Zhao, Y | 1 |
Chen, J; Chen, Y; Du, Q; Fu, Y; Jiang, M; Jiao, N; Liu, L; Sun, J; Wu, H; Xu, H; Zhu, Y | 1 |
Chen, J; Chen, YP; Du, Q; Fu, YX; Gao, YY; Lu, JF; Lv, GH; Lv, X; Shu, AM; Wang, W; Xu, HQ | 1 |
Lee, MK; Liu, B; Liu, K; Lu, C; Lv, G; Lv, X; Wu, Y; Xu, H | 1 |
Hou, J; Jiang, WL; Zhang, SP; Zhu, HB | 1 |
Li, L; Liu, H; Shen, J; Shi, Y; Wei, M; Xu, H | 1 |
6 other study(ies) available for loganin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Glucose; Inflammasomes; Kidney; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Pyroptosis | 2023 |
Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling.
Topics: Animals; Apoptosis; Diabetic Nephropathies; Drug Therapy, Combination; Glycation End Products, Advanced; Iridoid Glucosides; Iridoids; Male; Mice; Mice, Inbred C57BL; NADPH Oxidase 4; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Podocytes; Receptor for Advanced Glycation End Products; Signal Transduction | 2020 |
Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy.
Topics: Animals; Chemokine CCL2; Chemokine CCL8; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Glycation End Products, Advanced; Iridoids; Kidney; Macrophage Activation; Macrophages; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; RAW 264.7 Cells; Receptors, CCR1; Receptors, CCR2; Signal Transduction; Transforming Growth Factor beta1 | 2021 |
Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
Topics: Analysis of Variance; Animals; Blood Urea Nitrogen; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; DNA Primers; Dose-Response Relationship, Drug; Gene Expression Regulation; Glycation End Products, Advanced; Iridoids; Kidney; Malondialdehyde; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Molecular Structure; Oxidative Stress; Pancreas; Proteinuria; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Superoxide Dismutase | 2015 |
Effect of loganin on experimental diabetic nephropathy.
Topics: Animals; Blood Glucose; Cell Line; Cell Proliferation; Connective Tissue Growth Factor; Cornus; Cystatin C; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Glucose; Humans; Immunohistochemistry; Iridoids; Kidney; Male; MAP Kinase Signaling System; Rats; Rats, Sprague-Dawley; Weight Gain | 2012 |
Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress.
Topics: Animals; Antioxidants; Cell Cycle; Cell Line; Cell Proliferation; Cell Shape; Cornus; Diabetic Nephropathies; Flow Cytometry; Glutathione Peroxidase; Glycation End Products, Advanced; Glycosides; Iridoids; Malondialdehyde; Mesangial Cells; Microscopy, Fluorescence; Oxidative Stress; Rats; Reactive Oxygen Species; Superoxide Dismutase | 2006 |